Most Recent
Mayfair 101 founder denies troubled fund a Ponzi scheme
The embattled founder of Mayfair 101 investment group has denied allegations that its $80 million IPO Wealth fund is a failed Ponzi scheme as he fights the appointment of a provisional liquidator to the fund.
ASIC won’t bring action against Retail Food Group despite report of ‘particularly unjust’ conduct
Gloria Jeans' owner Retail Food Group has avoided enforcement action by the Australian Securities and Investments Commission after an investigation sparked by last year's damning parliamentary report into the franchise sector.
Opal Tower apartment owners file lawsuit against NSW Government
Owners of units in Sydney's Opal Tower have filed a lawsuit against the NSW Government and builder Icon after allegedly discovering more than 500 additional defects in the troubled building.
Crippled by COVID-19, swimwear brand Seafolly enters administration
Citing the "crippling financial impact" of the coronavirus pandemic, Australian swimwear company Seafolly has become the latest fashion retailer to enter voluntary administration.
Sequenom’s ‘incorporeal’ prenatal genetic test unpatentable, Ariosa tells Full Court
Ariosa Diagnostics is fighting to revoke a patent for noninvasive prenatal test owned by Sequenom, arguing it merely describes how to extract "incorporeal" genetic information that is naturally found within the DNA of an unborn foetus.
Judge scolds law firms behind competing Boral class actions
A judge has scolded the law firms behind competing shareholder class actions against Boral for delaying progress of the proceedings, but may wait until the High Court's ruling on the AMP class action beauty parade before deciding which of three potential class actions should move forward.
Brexit, COVID-19 no reason to alter security terms in Gladstone Ports class action, judge says
A judge has rejected claims by Gladstone Ports Corporation that security for costs in a $100 million class action by commercial fishing operators should not be paid through a London-based insurer because of the impact of Brexit and COVID-19.
Janssen files lawsuit to block generic version of HIV drug
Drug maker Janssen has fired off a lawsuit against Juno Pharmaceuticals for allegedly threatening to infringe a patent for its HIV drug Prezista with a generic version of the drug, one year after fending off generic competition from a different drug maker.
Government hit with $2.9M judgment in live export class action
The lead applicant in a class action against the Federal Government over its total ban on live cattle exports to Indonesia in 2011 has been awarded $2.9 million, potentially exposing the government to hundreds of millions of dollars in damages.
‘Groundless threats’: Sportsbet hit with cross claim in trade mark spat
Bookmaker Sportsbetting.com.au has accused rival Sportsbet of "groundless threats" as it hits back with a cross claim in a hotly disputed trade mark lawsuit between the two companies.